Patents by Inventor T. Conrad Gilliam

T. Conrad Gilliam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6068975
    Abstract: This invention provides an isolated, vertebrate nucleic acid molecule encoding the normal protein that prevents development of Wilson's disease. This invention also provides a nucleic acid molecule comprising a nucleic acid molecule of at least 15 nucleotides capable of specifically hybridizing with a sequence included within the sequence of the above-described nucleic acid molecule. Finally, this invention provides various uses of the isolated Wilson's disease gene.
    Type: Grant
    Filed: June 17, 1996
    Date of Patent: May 30, 2000
    Assignees: The Trustees of Columbia University in the City of New York, General Hospital Corporation
    Inventors: T. Conrad Gilliam, Rudolph E. Tanzi
  • Patent number: 5578493
    Abstract: This invention provides an isolated, vertebrate nucleic acid molecule encoding the normal protein that prevents development of Wilson's disease. This invention also provides a nucleic acid molecule comprising a nucleic acid molecule of at least 15 nucleotides capable of specifically hybridizing with a sequence included within the sequence of the above-described nucleic acid molecule. Finally, this invention provides various uses of the isolated Wilson's disease gene.
    Type: Grant
    Filed: September 1, 1993
    Date of Patent: November 26, 1996
    Assignees: The Trustees of Columbia University in the City of New York, General Hospital Corporation
    Inventors: T. Conrad Gilliam, Rudolph E. Tanzi